Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Blockade Is an Effective Radiosensitizing Strategy for the Treatment of Non-Small Cell Lung Cancer Harboring K-RAS Mutations

Konstantinidou, Georgia; Bey, E. A.; Rabellino, A.; Schuster, K.; Maira, M. S.; Gazdar, A. F.; Amici, A.; Boothman, D. A.; Scaglioni, P. P. (2009). Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Blockade Is an Effective Radiosensitizing Strategy for the Treatment of Non-Small Cell Lung Cancer Harboring K-RAS Mutations. Cancer research, 69(19), pp. 7644-7652. American Association for Cancer Research AACR 10.1158/0008-5472.CAN-09-0823

[img] Text
7644.full.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (854kB) | Request a copy

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Pharmacology

UniBE Contributor:

Konstantinidou, Georgia

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0008-5472

Publisher:

American Association for Cancer Research AACR

Language:

English

Submitter:

Georgia Konstantinidou

Date Deposited:

14 Jun 2018 09:30

Last Modified:

28 Oct 2019 08:16

Publisher DOI:

10.1158/0008-5472.CAN-09-0823

PubMed ID:

19789349

BORIS DOI:

10.7892/boris.96850

URI:

https://boris.unibe.ch/id/eprint/96850

Actions (login required)

Edit item Edit item
Provide Feedback